DENVER – Attorney General John Suthers today announced the University of Colorado at Denver and Health Sciences Center has been awarded $285,097 – Colorado’s portion of the Mylan Antitrust Litigation residual funds to support the Population-Based Palliative Care Research Network, or “PoPCRN.”
In 1998, the Attorneys General of 33 states, including Colorado, sued Mylan Laboratories, Inc. for violation of antitrust laws in connection with the sale of anti-anxiety, hypertension drugs, Lorazepam and Clorazepate. Among other things, the litigation alleged illegal agreements to monopolize the markets for these drugs, resulting in price increases of up to 3,000 percent. As part of the final approval of the settlement in 2002, the U.S. District Court in Washington, D.C. ordered Mylan to pay more than $100 million in refunds to consumers and government entities. The Court further ordered any remaining residual funds be used to benefit the health care needs of consumers injured by Mylan’s anticompetitive conduct.
“Given that a substantial portion of those injured by Mylan’s misconduct were seniors, it makes sense to put these funds into a program directed towards their care,” said Suthers. “The UCDHSC maintains the nation’s only hospice and palliative care research network, and it’s fitting that this money be used to further their important and needed research.”
UCDHSC will receive $285,097 to support the PoPCRN hospice/palliative care network and assist with the dissemination of “best practices” to people with advanced illnesses and those who care for them.
“Infrastructure funding is essential and helps facilitate translating our research findings back into practice – specifically getting ‘best practices’ evidence to the places where care is provided in a manner that is clinically useful,” said Jean Kutner, MD, MSPH, associate professor and acting head of the Division of Internal Medicine at the CU School of Medicine.
“With this money, we can provide more immediate evidence to organizations participating in our research of the dedication of the network to actually improving end-of-life care, not just studying it,” she added.
The University of Colorado at Denver and Health Sciences Center is one of three campuses in the University of Colorado system. Located in Denver and Aurora, the center includes schools of medicine, nursing, pharmacy, and dentistry, a graduate school and a teaching hospital. For more information, visit the Web site at www.uchsc.edu.